Go offline with the Player FM app!
MIRA Pharmaceuticals, Inc. Erez Aminov, CEO
Manage episode 373264159 series 2612480
MIRA is developing a new
molecular synthetic THC analog called MIRA1a, designed for the treatment of
adult patients with anxiety and cognitive decline, typically associated with
early-stage dementia.
MIRA’s initial focus will
be a dual path: potentially winning in traditional pain and anxiety markets as
well as the marijuana analog markets with a potentially safe and effective option if approved
by the FDA.
150 episodes
Manage episode 373264159 series 2612480
MIRA is developing a new
molecular synthetic THC analog called MIRA1a, designed for the treatment of
adult patients with anxiety and cognitive decline, typically associated with
early-stage dementia.
MIRA’s initial focus will
be a dual path: potentially winning in traditional pain and anxiety markets as
well as the marijuana analog markets with a potentially safe and effective option if approved
by the FDA.
150 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.